We also compared our TRGs-based risk model with seven well-established ESCC prognostic genes, including TP53, TRMT5, EGFR, KIF23, FAT1, KMT2D, and CTNNB1 (27–30). This evidence concerns the gene KMT2D and esophageal squamous cell carcinoma.